FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.8.6  |  FHIR Version n/a  User: [n/a]

385275000: Cutaneous AND/OR transdermal dosage form (qualifier value)


    Status: retired, Not sufficiently defined by necessary conditions definition status. Date: 31-Jan 2019. Module: SNOMED CT core module

    Descriptions:

    Id Description Lang Type Status Case? Module
    1479527018 Cutaneous AND/OR transdermal dosage form en Synonym Active Only initial character case insensitive SNOMED CT core module
    2660179010 Cutaneous AND/OR transdermal dosage form (qualifier value) en Fully specified name Active Only initial character case insensitive SNOMED CT core module


    0 descendants.

    Expanded Value Set


    Outbound Relationships Type Target Active Characteristic Refinability Group Values
    Cutaneous AND/OR transdermal dosage form Is a Type of drug preparation false Inferred relationship Existential restriction modifier
    Cutaneous AND/OR transdermal dosage form Is a Dose form by site prepared for false Inferred relationship Existential restriction modifier

    Inbound Relationships Type Active Source Characteristic Refinability Group
    Product containing myrrh Has manufactured dose form False Cutaneous AND/OR transdermal dosage form Inferred relationship Existential restriction modifier
    Product containing scopolamine in topical dosage form Has manufactured dose form False Cutaneous AND/OR transdermal dosage form Inferred relationship Existential restriction modifier
    Product containing precisely hydrogen peroxide 30 milligram/1 milliliter conventional release cutaneous solution (clinical drug) Has manufactured dose form False Cutaneous AND/OR transdermal dosage form Inferred relationship Existential restriction modifier
    Product containing ibuprofen and menthol Has manufactured dose form False Cutaneous AND/OR transdermal dosage form Inferred relationship Existential restriction modifier
    Progesterone 20mg topical cream Has manufactured dose form False Cutaneous AND/OR transdermal dosage form Inferred relationship Existential restriction modifier
    Product containing nicotine in topical dosage form Has manufactured dose form False Cutaneous AND/OR transdermal dosage form Inferred relationship Existential restriction modifier
    Product containing methoxsalen in topical dosage form Has manufactured dose form False Cutaneous AND/OR transdermal dosage form Inferred relationship Existential restriction modifier
    Product containing hydrogen peroxide in topical dosage form Has manufactured dose form False Cutaneous AND/OR transdermal dosage form Inferred relationship Existential restriction modifier
    Product containing oxiconazole Has manufactured dose form False Cutaneous AND/OR transdermal dosage form Inferred relationship Existential restriction modifier
    Product containing polymyxin B in topical dosage form Has manufactured dose form False Cutaneous AND/OR transdermal dosage form Inferred relationship Existential restriction modifier
    Product containing chlorhexidine and nystatin Has manufactured dose form False Cutaneous AND/OR transdermal dosage form Inferred relationship Existential restriction modifier
    Chlorhexidine obstetric 1% cream Has manufactured dose form False Cutaneous AND/OR transdermal dosage form Inferred relationship Existential restriction modifier
    Product containing clioquinol and hydrocortisone Has manufactured dose form False Cutaneous AND/OR transdermal dosage form Inferred relationship Existential restriction modifier
    Product containing miconazole in topical dosage form Has manufactured dose form False Cutaneous AND/OR transdermal dosage form Inferred relationship Existential restriction modifier
    Product containing prednisolone in topical dosage form Has manufactured dose form False Cutaneous AND/OR transdermal dosage form Inferred relationship Existential restriction modifier
    Product containing econazole in topical dosage form Has manufactured dose form False Cutaneous AND/OR transdermal dosage form Inferred relationship Existential restriction modifier
    Skin antifungal agent Has manufactured dose form False Cutaneous AND/OR transdermal dosage form Inferred relationship Existential restriction modifier
    Product containing edetate in topical dosage form Has manufactured dose form False Cutaneous AND/OR transdermal dosage form Inferred relationship Existential restriction modifier
    Product containing camphor and menthol Has manufactured dose form False Cutaneous AND/OR transdermal dosage form Inferred relationship Existential restriction modifier
    Product containing potassium in topical dosage form Has manufactured dose form False Cutaneous AND/OR transdermal dosage form Inferred relationship Existential restriction modifier
    Product containing butenafine Has manufactured dose form False Cutaneous AND/OR transdermal dosage form Inferred relationship Existential restriction modifier
    Product containing aciclovir in topical dosage form Has manufactured dose form False Cutaneous AND/OR transdermal dosage form Inferred relationship Existential restriction modifier
    Estradiol 0.06mg/day transdermal patch Has manufactured dose form False Cutaneous AND/OR transdermal dosage form Inferred relationship Existential restriction modifier
    Chlorhexidine gluconate pink 0.05% solution Has manufactured dose form False Cutaneous AND/OR transdermal dosage form Inferred relationship Existential restriction modifier
    Product containing precisely hydrocortisone acetate 10 milligram/1 gram and neomycin sulfate 5 milligram/1 gram conventional release cutaneous cream Has manufactured dose form False Cutaneous AND/OR transdermal dosage form Inferred relationship Existential restriction modifier
    Product containing benzocaine in topical dosage form Has manufactured dose form False Cutaneous AND/OR transdermal dosage form Inferred relationship Existential restriction modifier
    Product containing undecenoate Has manufactured dose form False Cutaneous AND/OR transdermal dosage form Inferred relationship Existential restriction modifier
    Product containing precisely clotrimazole 10 milligram/1 milliliter conventional release cutaneous solution Has manufactured dose form False Cutaneous AND/OR transdermal dosage form Inferred relationship Existential restriction modifier
    Product containing precisely chlorhexidine diacetate 500 microgram/1 milliliter conventional release cutaneous solution (clinical drug) Has manufactured dose form False Cutaneous AND/OR transdermal dosage form Inferred relationship Existential restriction modifier
    Product containing benzocaine and phenol Has manufactured dose form False Cutaneous AND/OR transdermal dosage form Inferred relationship Existential restriction modifier
    Product containing precisely chlorhexidine gluconate 500 microgram/1 milliliter conventional release cutaneous solution Has manufactured dose form False Cutaneous AND/OR transdermal dosage form Inferred relationship Existential restriction modifier
    Metronidazole gel Has manufactured dose form False Cutaneous AND/OR transdermal dosage form Inferred relationship Existential restriction modifier
    Product containing rivastigmine in topical dosage form Has manufactured dose form False Cutaneous AND/OR transdermal dosage form Inferred relationship Existential restriction modifier
    Camphor + eucalyptus + menthol Has manufactured dose form False Cutaneous AND/OR transdermal dosage form Inferred relationship Existential restriction modifier
    Product containing camphor and chloroxylenol Has manufactured dose form False Cutaneous AND/OR transdermal dosage form Inferred relationship Existential restriction modifier
    Product containing chlorhexidine and tolnaftate Has manufactured dose form False Cutaneous AND/OR transdermal dosage form Inferred relationship Existential restriction modifier
    Product containing allantoin and lidocaine Has manufactured dose form False Cutaneous AND/OR transdermal dosage form Inferred relationship Existential restriction modifier
    Topical form corticosteroids Has manufactured dose form False Cutaneous AND/OR transdermal dosage form Inferred relationship Existential restriction modifier
    Product containing benzocaine and triclosan Has manufactured dose form False Cutaneous AND/OR transdermal dosage form Inferred relationship Existential restriction modifier
    Product containing phenylephrine in topical dosage form Has manufactured dose form False Cutaneous AND/OR transdermal dosage form Inferred relationship Existential restriction modifier
    Chlorhexidine gluconate 0.05% topical liquid sachet Has manufactured dose form False Cutaneous AND/OR transdermal dosage form Inferred relationship Existential restriction modifier
    Product containing fluprednidene and miconazole Has manufactured dose form False Cutaneous AND/OR transdermal dosage form Inferred relationship Existential restriction modifier
    Product containing mupirocin in topical dosage form Has manufactured dose form False Cutaneous AND/OR transdermal dosage form Inferred relationship Existential restriction modifier
    Product containing potassium chlorate Has manufactured dose form False Cutaneous AND/OR transdermal dosage form Inferred relationship Existential restriction modifier
    Product containing tolnaftate Has manufactured dose form False Cutaneous AND/OR transdermal dosage form Inferred relationship Existential restriction modifier
    Product containing fluocinolone in topical dosage form Has manufactured dose form False Cutaneous AND/OR transdermal dosage form Inferred relationship Existential restriction modifier
    Product containing urea in topical dosage form Has manufactured dose form False Cutaneous AND/OR transdermal dosage form Inferred relationship Existential restriction modifier
    Product containing nicotinamide in topical dosage form Has manufactured dose form False Cutaneous AND/OR transdermal dosage form Inferred relationship Existential restriction modifier
    Product containing benzocaine and mepyramine Has manufactured dose form False Cutaneous AND/OR transdermal dosage form Inferred relationship Existential restriction modifier
    Hydrocortisone acetate + neomycin sulfate + polymyxin b sulfate 5mg/3.5mg/10000unit cream Has manufactured dose form False Cutaneous AND/OR transdermal dosage form Inferred relationship Existential restriction modifier
    Product containing sulfacetamide in topical dosage form Has manufactured dose form False Cutaneous AND/OR transdermal dosage form Inferred relationship Existential restriction modifier
    Product containing chlorhexidine in topical dosage form Has manufactured dose form False Cutaneous AND/OR transdermal dosage form Inferred relationship Existential restriction modifier
    Product containing brilliant green and methylrosanilinium chloride Has manufactured dose form False Cutaneous AND/OR transdermal dosage form Inferred relationship Existential restriction modifier
    Product containing methylrosanilinium chloride Has manufactured dose form False Cutaneous AND/OR transdermal dosage form Inferred relationship Existential restriction modifier
    Product containing precisely bacitracin 500 unit/1 gram conventional release cutaneous ointment (clinical drug) Has manufactured dose form False Cutaneous AND/OR transdermal dosage form Inferred relationship Existential restriction modifier
    Product containing amorolfine Has manufactured dose form False Cutaneous AND/OR transdermal dosage form Inferred relationship Existential restriction modifier
    Product containing benzocaine and resorcinol Has manufactured dose form False Cutaneous AND/OR transdermal dosage form Inferred relationship Existential restriction modifier
    Product containing bacitracin and neomycin and polymyxin B and pramocaine Has manufactured dose form False Cutaneous AND/OR transdermal dosage form Inferred relationship Existential restriction modifier
    Product containing colistin in topical dosage form Has manufactured dose form False Cutaneous AND/OR transdermal dosage form Inferred relationship Existential restriction modifier
    Product containing cinchocaine in topical dosage form Has manufactured dose form False Cutaneous AND/OR transdermal dosage form Inferred relationship Existential restriction modifier
    Product containing precisely chlorhexidine gluconate 1 milligram/1 milliliter conventional release cutaneous solution (clinical drug) Has manufactured dose form False Cutaneous AND/OR transdermal dosage form Inferred relationship Existential restriction modifier
    Product containing benzoyl peroxide and hydrocortisone Has manufactured dose form False Cutaneous AND/OR transdermal dosage form Inferred relationship Existential restriction modifier
    Undecylenic acid and undecylenate salt Has manufactured dose form False Cutaneous AND/OR transdermal dosage form Inferred relationship Existential restriction modifier
    Product containing calamine and zinc oxide Has manufactured dose form False Cutaneous AND/OR transdermal dosage form Inferred relationship Existential restriction modifier
    Product containing lithium succinate Has manufactured dose form False Cutaneous AND/OR transdermal dosage form Inferred relationship Existential restriction modifier
    Product containing lidocaine and zinc oxide Has manufactured dose form False Cutaneous AND/OR transdermal dosage form Inferred relationship Existential restriction modifier
    Product containing epinephrine in topical dosage form Has manufactured dose form False Cutaneous AND/OR transdermal dosage form Inferred relationship Existential restriction modifier
    Product containing benzocaine and chloroxylenol Has manufactured dose form False Cutaneous AND/OR transdermal dosage form Inferred relationship Existential restriction modifier
    Product containing aldioxa and chloroxylenol Has manufactured dose form False Cutaneous AND/OR transdermal dosage form Inferred relationship Existential restriction modifier
    Product containing zinc in topical dosage form Has manufactured dose form False Cutaneous AND/OR transdermal dosage form Inferred relationship Existential restriction modifier
    Product containing lithium succinate and zinc sulfate Has manufactured dose form False Cutaneous AND/OR transdermal dosage form Inferred relationship Existential restriction modifier
    Product containing mequinol and tretinoin Has manufactured dose form False Cutaneous AND/OR transdermal dosage form Inferred relationship Existential restriction modifier
    Product containing oxytetracycline in topical dosage form Has manufactured dose form False Cutaneous AND/OR transdermal dosage form Inferred relationship Existential restriction modifier
    Product containing sodium propionate Has manufactured dose form False Cutaneous AND/OR transdermal dosage form Inferred relationship Existential restriction modifier
    Product containing calamine Has manufactured dose form False Cutaneous AND/OR transdermal dosage form Inferred relationship Existential restriction modifier
    Product containing chlorhexidine and isopropyl alcohol Has manufactured dose form False Cutaneous AND/OR transdermal dosage form Inferred relationship Existential restriction modifier
    Product containing chlorhexidine and neomycin Has manufactured dose form False Cutaneous AND/OR transdermal dosage form Inferred relationship Existential restriction modifier
    Product containing boric acid in topical dosage form Has manufactured dose form False Cutaneous AND/OR transdermal dosage form Inferred relationship Existential restriction modifier
    Product containing calcitriol in topical dosage form Has manufactured dose form False Cutaneous AND/OR transdermal dosage form Inferred relationship Existential restriction modifier
    Product containing sodium bicarbonate in topical dosage form Has manufactured dose form False Cutaneous AND/OR transdermal dosage form Inferred relationship Existential restriction modifier
    Product containing benzalkonium in topical dosage form Has manufactured dose form False Cutaneous AND/OR transdermal dosage form Inferred relationship Existential restriction modifier
    Product containing buprenorphine in topical dosage form Has manufactured dose form False Cutaneous AND/OR transdermal dosage form Inferred relationship Existential restriction modifier
    Product containing doxepin in topical dosage form Has manufactured dose form False Cutaneous AND/OR transdermal dosage form Inferred relationship Existential restriction modifier
    Trichloroacetic acid 15% Has manufactured dose form False Cutaneous AND/OR transdermal dosage form Inferred relationship Existential restriction modifier
    Amethocaine 4% gel+occlusive dressing Has manufactured dose form False Cutaneous AND/OR transdermal dosage form Inferred relationship Existential restriction modifier
    Product containing precisely phenol 20 milligram/1 milliliter conventional release cutaneous solution (clinical drug) Has manufactured dose form False Cutaneous AND/OR transdermal dosage form Inferred relationship Existential restriction modifier
    Amethocaine 4% gel+dressing Has manufactured dose form False Cutaneous AND/OR transdermal dosage form Inferred relationship Existential restriction modifier
    Product containing precisely phenol 10 milligram/1 milliliter conventional release cutaneous solution (clinical drug) Has manufactured dose form False Cutaneous AND/OR transdermal dosage form Inferred relationship Existential restriction modifier
    Product containing precisely tetracaine 40 milligram/1 gram conventional release cutaneous gel Has manufactured dose form False Cutaneous AND/OR transdermal dosage form Inferred relationship Existential restriction modifier
    Product containing precisely tetracaine hydrochloride 10 milligram/1 gram conventional release cutaneous cream Has manufactured dose form False Cutaneous AND/OR transdermal dosage form Inferred relationship Existential restriction modifier
    Product containing precisely tetracaine hydrochloride 20 milligram/1 milliliter conventional release cutaneous solution (clinical drug) Has manufactured dose form False Cutaneous AND/OR transdermal dosage form Inferred relationship Existential restriction modifier
    Product containing tetracaine in topical dosage form Has manufactured dose form False Cutaneous AND/OR transdermal dosage form Inferred relationship Existential restriction modifier
    Product containing bexarotene in topical dosage form Has manufactured dose form False Cutaneous AND/OR transdermal dosage form Inferred relationship Existential restriction modifier
    Product containing precisely bexarotene 10 milligram/1 gram conventional release cutaneous gel (clinical drug) Has manufactured dose form False Cutaneous AND/OR transdermal dosage form Inferred relationship Existential restriction modifier
    Product containing precisely menthol 30 microgram/1 milligram and methyl salicylate 100 microgram/1 milligram conventional release cutaneous patch (clinical drug) Has manufactured dose form False Cutaneous AND/OR transdermal dosage form Inferred relationship Existential restriction modifier
    Product containing precisely tetracaine hydrochloride 20 milligram/1 gram conventional release cutaneous gel (clinical drug) Has manufactured dose form False Cutaneous AND/OR transdermal dosage form Inferred relationship Existential restriction modifier
    Product containing camphor and menthol and methyl salicylate Has manufactured dose form False Cutaneous AND/OR transdermal dosage form Inferred relationship Existential restriction modifier
    Product containing precisely calcitriol 3 microgram/1 gram conventional release cutaneous ointment Has manufactured dose form False Cutaneous AND/OR transdermal dosage form Inferred relationship Existential restriction modifier
    Product containing levonorgestrel in topical dosage form Has manufactured dose form False Cutaneous AND/OR transdermal dosage form Inferred relationship Existential restriction modifier
    Product containing precisely camphor 12 microgram/1 milligram and menthol 57 microgram/1 milligram and methyl salicylate 63 microgram/1 milligram conventional release cutaneous patch (clinical drug) Has manufactured dose form False Cutaneous AND/OR transdermal dosage form Inferred relationship Existential restriction modifier
    Product containing benzalkonium and cetrimide Has manufactured dose form False Cutaneous AND/OR transdermal dosage form Inferred relationship Existential restriction modifier

    Start Previous Page 12 of 55 Next End


    This concept is not in any reference sets

    Back to Start